Latest Foreign Investment Review News

Mandalay Resources Corporation has agreed to a plan of arrangement to be acquired by Alkane Resources Limited through its wholly owned subsidiary. Mandalay shareholders will receive 7.875 Alkane shares for each Mandalay share held, creating a combined gold and antimony producer with a strong balance sheet and diversified operations across Australia and Sweden.

Alkane Resources has secured key regulatory approvals from FIRB and ASIC, paving the way for its planned merger with Mandalay Resources. This milestone brings the companies closer to creating a diversified Australian gold and antimony producer.

TPC Consolidated Limited has extended critical deadlines for its acquisition scheme with Wollar Solar Holding, awaiting Foreign Investment Review Board approval. The move delays the scheme's completion but keeps the deal alive for now.

Duxton Farms Ltd is set to transform its agricultural portfolio through a strategic merger with four private companies, alongside a $4 million placement and a special dividend, aiming to boost scale and diversification.

MIXI Australia has launched a recommended all-cash takeover offer for PointsBet at $1.20 per share, significantly outpacing rival Betr Entertainment’s scrip proposal. The PointsBet board unanimously supports MIXI’s bid, highlighting its certainty and premium value.

Alkane Resources has moved forward with its planned merger with Mandalay Resources, scheduling shareholder meetings for late July to approve the deal that would create a diversified Australian-focused gold and antimony producer.

PointsBet shareholders have voted in favour of the proposed $1.20 per share acquisition by MIXI, Inc, marking a significant premium and clearing a key hurdle ahead of court approval.

Envirosuite has secured a key regulatory green light from FIRB for its acquisition by Ideagen, moving the proposed Scheme of Arrangement closer to shareholder approval.

Alkane Resources has secured Swedish regulatory approval for its proposed merger with Mandalay Resources, advancing a significant consolidation in the gold and antimony mining sector. The deal now awaits further approvals before shareholder votes expected in July.

Mayne Pharma shareholders have overwhelmingly approved the scheme of arrangement for Cosette Pharmaceuticals to acquire the company at $7.40 per share, despite ongoing legal challenges and regulatory approvals still pending.

Sumitomo Corporation's subsidiary has gained crucial Foreign Investment Review Board approval to invest in Tivan Limited's Speewah Fluorite Project, paving the way for a significant joint venture.

PointsBet has released a supplementary scheme booklet revealing an improved $1.20 per share cash offer from MIXI, alongside a postponed shareholder meeting now set for June 25. The deal, backed unanimously by the PointsBet board, faces final court and regulatory approvals.